New Delhi: Shares of Emcure Pharmaceuticals Ltd on Wednesday closed at a premium of over 35 per cent against the issue price of Rs 1,008.The stock started trading at Rs 1,325.05, up 31.45 per cent on both BSE and NSE.During the day, the company's shares rose 37.30 per cent to Rs 1,384 on BSE...
New Delhi: Shares of Emcure Pharmaceuticals Ltd were listed at a premium of over 31 per cent over the issue price of Rs 1,008 on Wednesday.The stock started trading at Rs 1,325.05, up 31.45 per cent on both BSE and NSE.Later, the company's shares rose 37.30 percent to Rs 1,384 on BSE and...
New Delhi: The initial public offering (IPO) of Bain Capital-backed Emcure Pharmaceuticals Ltd was subscribed 67.87 times on the last day of the offer on Friday amid enthusiastic participation from institutional buyers.According to NSE data, bids were received for 92,99,97,390 shares against...
New Delhi: Bain Capital-backed Emcure Pharmaceuticals Ltd's initial public offering (IPO) received 4.98 times subscription on the second day of the offering on Thursday amid encouraging participation from institutional investors.The initial share sale received bids for 6,81,87,028 shares...
New Delhi: The initial public offering (IPO) of Bain Capital-backed Emcure Pharmaceuticals Ltd was fully subscribed 1.32 times on the first day of the share sale on Wednesday amid enthusiastic participation from institutional investors.According to NSE data, bids were received for 1,80,25,840...
Emcure Pharmaceuticals, backed by Bain Capital in New Delhi, said on Tuesday it had raised Rs 583 crore from anchor investors a day before the opening of its initial offer for sale of shares for public subscription.The anchor book includes investors including HDFC Mutual Fund, ICICI Prudential...
Emcure Pharmaceuticals, backed by Bain Capital in New Delhi, said on Friday it has set a price band of Rs 960 to Rs 1,008 per share for its Rs 1,952-crore initial public offering (IPO).The initial share sale will be available for public subscription from July 3 to 5 and bidding for anchor...
New Delhi: Bain Capital-backed Emcure Pharmaceuticals is set to launch its initial public offering (IPO) on July 3.According to the red herring prospectus (RHP), the initial share sale will end on July 5 and bidding for anchor investors will open for one day on July 2.The IPO comprises...
New Delhi: Electric two-wheeler startup Ola Electric and Bain Capital-backed Emcure Pharmaceuticals have received approval from Sebi to raise funds through initial public offerings (IPOs), an update with the regulator showed on Thursday. markets.The two companies, which filed their preliminary...
New Delhi: Emcure Pharmaceuticals Ltd and its arm Gennova Biopharmaceutical have settled all legal disputes with HDT Bio Corp and signed a long-term agreement to develop mRNA vaccines, the company said on Thursday.Under the agreement, the litigation between them, including the US court and the...